The number of active joints and sLRPl levels at enrollment and 6-month visit.
| JIA Category | No. Active Joints at Enrollment, Median (IQR) | No. Active Joints at 6-month Visit, Median (IQR) | sLRP at Enrollment, ng/mL, Median (IQR) | sLRP at 6-month, ng/mL, Median (IQR) |
|---|---|---|---|---|
| Polyarthritis RF− | 9.0 (5.0–18.0) | 2.5 (0.0–4.7) | 26.9 (9.5–87.1) | 26.8 (13.7–59.6) |
| Oligoarthritis | 2.0 (1.0–3.0) | 1.0 (0.0–2.0) | 52.8 (19.7–183.2) | 43.2 (11.4–183.1) |
| PsA | 3.0 (2.0–9.0) | 0.0 (0.0–2.0) | 70.7 (21.0–261.6) | 25.7 (1.1–139.0) |
| Polyarthritis RF+ | 19.0 (7.0–27.0) | 0.0 (0.0–2.5) | 20.5 (8.4–45.5) | 17.9 (6.6–43.8) |
| ERA | 3.0 (1.0–8.0) | 0.0 (0.0–1.0) | 24.7 (7.1–56.5) | 30.4 (2.8–52.4) |
| Undifferentiate d | 2.0 (1.0–7.0) | 0.0 (1.0–5.0) | 27.5 (20.0–84.1) | 18.1 (16.0–75.8) |
| Total | 5.0 (2.0–12.0) | 1.0 (0.0–3.0) | 35.4 (14.2–82.2) | 27.5 (12.9–64.5) |
ERA: enthesitis-related arthritis; PsA: psoriatic arthritis; RF: rheumatoid factor; sLRP1: soluble low-density lipoprotein receptor-related protein 1.